Christianson Mark 4

What Happened

• Mark Christianson, Business Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), disposed of 1,812 shares as payment for tax liabilities related to equity compensation. The shares were reported at $0.68 each, for a total value of $1,232. This was a tax-withholding disposition (not an open-market sale) commonly used to cover withholding obligations.

Key Details

• Transaction date: 2026-02-18
• Reported filing date (SEC Form 4): 2026-02-20 — filed promptly after the transaction
• Price per share: $0.68; Shares disposed: 1,812; Total value: $1,232
• Transaction code: F (payment of exercise price or tax liability — indicates shares were withheld/used to satisfy tax obligations)
• Shares owned after the transaction: not disclosed in the filing
• No indication of a 10b5-1 plan or other special trading plan in this filing

Context

• Tax-withholding dispositions are routine when insiders exercise options or receive awards; the company withholds or accepts shares to meet tax obligations rather than the insider selling shares in the open market. Such transactions reduce the insider’s holdings but are not a clear signal of bullish or bearish intent.